Doxorubicin (Adriamycin) cardiotoxicity
Weisburst, M.R.; Pearlman, E.S.; Capone, R.J.
Connecticut Medicine 44(3): 133-136
1980
ISSN/ISBN: 0010-6178 PMID: 7363615 Document Number: 157417
Document emailed within 1 workday
Related Documents
Weisburst, M.R.; Pearlman, E.S.; Capone, R.J. 1980: Doxorubicin (Adriamycin) cardiotoxicity Connecticut Medicine 44(3): 133-136Van Vleet, J.F.; Ferrans, V.J.; Badylak, S.F. 1982: Effect of thyroid hormone supplementation on chronic doxorubicin (adriamycin)-induced cardiotoxicity and serum concentrations of T3 and T4 in dogs American Journal of Veterinary Research 43(12): 2173-2182
Adam, Z.; Elbl, L.; Vorlícek, J.; Hájek, R.; Tomíska, M.; Hejlová, N.; Králová, E.; Novotná, H. 1994: Lower cardiotoxicity of adriamycin during continuous administration in patients with refractory multiple myeloma treated with cyclophosphamide, vincristine, adriamycin and dexamethasone (C-VAD) Vnitrni Lekarstvi 40(8): 506-512
Recalcatri, F.; Villa, A.; Belli, C. 1982: Adriamycin cardiotoxicity Giornale Italiano di Cardiologia 12(8): 612-616
Gamna, G.; Lovisetto, P.; Pochnettino, G.; Biarese, V. 1974: Adriamycin: cardiotoxicity Bollettino Della Societa Italiana di Cardiologia 19(7): 633-670
Brockmeier, F.K. 1984: Cardiotoxicity of doxorubicin in children Nederlands Tijdschrift Voor Geneeskunde 128(43): 2063
Pilon, J.W.; Naeff, M.S.; Taminiau, J.A. 1984: Cardiotoxicity of doxorubicin in children Nederlands Tijdschrift Voor Geneeskunde 128(28): 1339-1343
Alexander, J.; Berger, H.J.; Zaret, B.L. 1979: Testing for doxorubicin cardiotoxicity New England Journal of Medicine 300(24): 1393
Fajardo, L.F.; Eltringham, J.R.; Steward, J.R. 1976: Combined cardiotoxicity of adriamycin and x-radiation Laboratory Investigation; a Journal of Technical Methods and Pathology 34(1): 86-96
Bossa, R.; Bissoli, M.; Chiericozzi, M.; Cozzi, R.; Galatulas, I.; Salvatore, G. 1996: Reduction of adriamycin cardiotoxicity by enoximone Anticancer Research 16(1): 141-143
Zieba, R.; Wagrowska-Danilewicz, M.łg. 2003: Influence of carnosine on the cardiotoxicity of doxorubicin in rabbits Polish Journal of Pharmacology 55(6): 1079-1087
Russo, S.; Filippelli, W.; Ferraraccio, F.; Berrino, L.; Guarino, V.; Rossi, F. 1994: Effects of S-adenosylmethionine (SAMe) on doxorubicin-induced cardiotoxicity in the rat Journal of Medicine 25(1-2): 65-89
Andreani, A.; Bossa, R.; Galatulas, I.; Ninci, M.A.; Rambaldi, M. 1991: Reduction of adriamycin cardiotoxicity by a new cardiotonic agent Anticancer Research 11(1): 375-377
Ramos, A.; Meyer, R.A.; Korfhagen, J.; Wong, K.Y.; Kaplan, S. 1976: Echocardiographic evaluation of adriamycin cardiotoxicity in children Cancer Treatment Reports 60(9): 1281-1284
Bellelli, A.; Giomini, M.; Giuliani, A.M.; Giustini, M.; Lorenzon, I.; Rusconi, V.; Sezzi, M.L.; Trotta, E.; Belleli, L. 1988: Antitumor effect and cardiotoxicity of a doxorubicin-lecithin association Anticancer Research 8(1): 177-186
Hamaguchi, T.; Azuma, J.; Awata, N.; Ohta, H.; Takihara, K.; Harada, H.; Kishimoto, S.; Sperelakis, N. 1988: Reduction of doxorubicin-induced cardiotoxicity in mice by taurine Research Communications in Chemical Pathology and Pharmacology 59(1): 21-30
Herrmann, H.J.; Massow, S.; Moritz, V.; Norden, C.; Kühne, C. 1987: Peculiarities of adriamycin cardiotoxicity in spontaneously hypertensive rats (SHR) Biomedica Biochimica Acta 46(8-9): S593-S596
Jensen, R.A.; Acton, E.M.; Peters, J.H. 1984: Doxorubicin cardiotoxicity in the rat: comparison of electrocardiogram, transmembrane potential, and structural effects Journal of Cardiovascular Pharmacology 6(1): 186-200
Köseoğlu, V.; Berberoğlu, S.; Karademir, S.; Kismet, E.; Yurttutan, N.; Demirkaya, E.; Sungur, M.; Alehan, D. 2005: Cardiac troponin I: is it a marker to detect cardiotoxicity in children treated with doxorubicin? Turkish Journal of Pediatrics 47(1): 17-22
Van Hoesel, Q.G.; Steerenberg, P.A.; Vos, J.G.; Hillen, F.C.; Dormans, J.A. 1984: Antitumor effect, cardiotoxicity, and nephrotoxicity of doxorubicin in the IgM solid immunocytoma-bearing LOU/M/WSL rat Journal of the National Cancer Institute 72(5): 1141-1150